Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
CNY 85.81
(-0.8%)
CNY 85.81
(-0.8%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 24.36 Million CNY | -24.06% |
| 2022 | 32.08 Million CNY | -13.2% |
| 2021 | 36.96 Million CNY | 163.87% |
| 2020 | 14 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 21.31 Million CNY | 0.0% |
| 2024 Q2 | 18.26 Million CNY | 0.0% |
| 2024 Q3 | 14.57 Million CNY | 0.0% |
| 2023 Q4 | 24.36 Million CNY | -11.93% |
| 2023 FY | 24.36 Million CNY | -24.06% |
| 2023 Q3 | 27.66 Million CNY | -16.25% |
| 2023 Q2 | 33.03 Million CNY | 12.82% |
| 2023 Q1 | 29.28 Million CNY | -8.74% |
| 2022 Q4 | 32.08 Million CNY | 5.81% |
| 2022 Q3 | 30.32 Million CNY | -13.73% |
| 2022 Q2 | 35.15 Million CNY | 2.69% |
| 2022 Q1 | 34.23 Million CNY | -7.4% |
| 2022 FY | 32.08 Million CNY | -13.2% |
| 2021 FY | 36.96 Million CNY | 163.87% |
| 2021 Q1 | 12.77 Million CNY | 0.0% |
| 2021 Q2 | 41.14 Million CNY | 222.16% |
| 2021 Q3 | 38.91 Million CNY | -5.42% |
| 2021 Q4 | 36.96 Million CNY | -5.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 FY | 14 Million CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |